Abstract Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age 1 . Here we analysed immune responses following vaccination with the BNT162b2 mR...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!